Atlas Trials

Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease

Clinical trial NCT04818892 · COMPLETED

Trial details

NCT number
NCT04818892
Sponsor
University of Wisconsin, Madison
Status
COMPLETED
Study type
OBSERVATIONAL
IBDCovid19 Vaccine
Start date
2021-03-26
Primary completion
2022-11-11
Enrollment
222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.